- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Fulgent Genetics Inc (FLGT)
Fulgent Genetics Inc stock price live, this page displays NASDAQ FLGT stock exchange data. View the FLGT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Fulgent Genetics Inc real time stock price chart below.
What Is the Fulgent Genetics Inc Stock Price Today?
The Fulgent Genetics Inc stock price today is 22.21.
What Is the Stock Symbol for Fulgent Genetics Inc?
The stock symbol for Fulgent Genetics Inc is ""FLGT.""
What Stock Exchange Does Fulgent Genetics Inc Trade On?
Fulgent Genetics Inc is listed and trades on the NASDAQ stock exchange.
Is Fulgent Genetics Inc a Good Stock to Buy?
Determining whether Fulgent Genetics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the FLGT quote. (ISIN: US3596641098)
What Is the Fulgent Genetics Inc Stock Price Today?
The Fulgent Genetics Inc stock price today is 22.21.
What Is the Stock Symbol for Fulgent Genetics Inc?
The stock symbol for Fulgent Genetics Inc is ""FLGT.""
What Stock Exchange Does Fulgent Genetics Inc Trade On?
Fulgent Genetics Inc is listed and trades on the NASDAQ stock exchange.
Is Fulgent Genetics Inc a Good Stock to Buy?
Determining whether Fulgent Genetics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the FLGT quote. (ISIN: US3596641098)
22.21
+0.18(+0.79%)
Real-time Data·
Fair Value
An estimate of a Fulgent Genetics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
21.83
22.33
52 wk Range
14.57
23.56
FLGT Scorecard
Full Analysis
Management has been aggressively buying back shares
FLGT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Fulgent Genetics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
21.8322.33
52 wk Range
14.5723.56
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
FLGT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Fulgent Genetics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
25.33
Upside
+14.06%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Fulgent Genetics Inc Company Profile
Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company’s clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. The company was founded in 2011 and is headquartered in El Monte, California.
Fulgent Genetics Inc Earnings Call Summary for Q2/2025
- Q2 2025 revenue of $81.8M, up 16% YoY, surpassing $76.21M forecast; EPS of $0.07 missed $-0.18 estimate
- Stock surged 11.47% to $19.15 in pre-market trading despite EPS miss; company maintains strong liquidity with 6.32 current ratio
- Full-year revenue guidance raised to $310-$320M, indicating 14% YoY growth; FID-seven trial enrollment to complete by end of 2025
- Expanded genomic testing capabilities and new product launches highlighted; growth in Precision Diagnostics driven by VA contract
- CEO reports growth in laboratory services; CCO states company is 'firing on all cylinders' and investing in expansion
Last Updated: 01/08/2025, 14:38
Read Full TranscriptCompare FLGT to Peers and Sector
Metrics to compare | FLGT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFLGTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −13.2x | −1.2x | −0.6x | |
PEG Ratio | −0.19 | 0.00 | 0.00 | |
Price/Book | 0.6x | 1.0x | 2.6x | |
Price / LTM Sales | 2.2x | 1.0x | 3.3x | |
Upside (Analyst Target) | 13.5% | 39.1% | 39.1% | |
Fair Value Upside | Unlock | 5.0% | 5.4% | Unlock |
Analyst Ratings
2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 25.33
(+14.06% Upside)
Earnings
Latest Release
Aug 01, 2025
EPS / Forecast
0.07 / -0.18
Revenue / Forecast
81.80M / 76.21M
People Also Watch
FAQ
What Stock Exchange Does Fulgent Genetics Trade On?
Fulgent Genetics is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Fulgent Genetics?
The stock symbol for Fulgent Genetics is "FLGT."
What Is the Fulgent Genetics Market Cap?
As of today, Fulgent Genetics market cap is 681.05M.
What Is Fulgent Genetics's Earnings Per Share (TTM)?
The Fulgent Genetics EPS (TTM) is -1.67.
When Is the Next Fulgent Genetics Earnings Date?
Fulgent Genetics will release its next earnings report on 04 Nov 2025.
From a Technical Analysis Perspective, Is FLGT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Fulgent Genetics Stock Split?
Fulgent Genetics has split 0 times.
How Many Employees Does Fulgent Genetics Have?
Fulgent Genetics has 1313 employees.
What is the current trading status of Fulgent Genetics (FLGT)?
As of 29 Aug 2025, Fulgent Genetics (FLGT) is trading at a price of 22.21, with a previous close of 22.03. The stock has fluctuated within a day range of 21.83 to 22.33, while its 52-week range spans from 14.57 to 23.56.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.